6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Disease, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, DR; Fetterer, DP; Holmes, WW; Taylor, SL | 1 |
| Chu, HW; Kosmider, B; Mason, RJ; Messier, EM | 1 |
2 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Disease, Pulmonary
| Article | Year |
|---|---|
Evaluation of protease inhibitors and an antioxidant for treatment of sulfur mustard-induced toxic lung injury.
Topics: Animals; Antioxidants; Aprotinin; Bronchoalveolar Lavage Fluid; Chemical Warfare Agents; Chromans; Cytokines; Drug Therapy, Combination; Hydroxamic Acids; Indoles; Injections, Intraperitoneal; Injections, Intravenous; Intubation, Intratracheal; Lung; Lung Diseases; Male; Mustard Gas; Proteins; Rats; Rats, Sprague-Dawley; Respiratory Function Tests; Serine Proteinase Inhibitors | 2009 |
Human alveolar epithelial cell injury induced by cigarette smoke.
Topics: Acetylcysteine; Active Transport, Cell Nucleus; Apoptosis; Benzimidazoles; Chromans; Epithelial Cells; Humans; In Situ Nick-End Labeling; Lung Diseases; Microscopy, Fluorescence; Necrosis; NF-E2-Related Factor 2; Oxidative Stress; Phenotype; Propidium; Pulmonary Alveoli; Smoking | 2011 |